|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2011-3-30
|
|
pubmed:abstractText |
Chronic kidney disease (CKD) and low serum total testosterone (TT) concentrations are independent predictors of mortality risk in the general population, but their combined potential for improved mortality risk stratification is unknown.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1421-9670
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2011 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
33
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
209-17
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Low serum testosterone is associated with increased mortality in men with stage 3 or greater nephropathy.
|
|
pubmed:affiliation |
Institute of Clinical Chemistry and Laboratory Medicine, University of Greifswald, Germany. robin.haring@uni-greifswald.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
